Symptom Management in Patients Undergoing New Treatment Modalities for Lung Cancer
New treatment modalities for lung cancer, including targeted therapy and immunotherapy, have contributed to improved patient survival rates. However, these treatments come with unique adverse effects. The nurse’s role in managing symptoms of these adverse effects requires an understanding of treatment mechanisms of action and common side effects.
Course Details
Overview
New treatment modalities for lung cancer, including targeted therapy and immunotherapy, have contributed to improved patient survival rates. However, these treatments come with unique adverse effects. The nurse’s role in managing symptoms of these adverse effects requires an understanding of treatment mechanisms of action and common side effects.
Presented by:
Monica L. Beck, PhD, RN, OCN, CNE; Haley Hoy, PhD, ACNP; and Rachel McMahill, MSN, RN, OCN
Monica L. Beck is an assistant professor at the University of Alabama Huntsville College of Nursing in Huntsville. Haley Hoy is a professor at the University of Alabama Huntsville College of Nursing. Rachel McMahill is a clinical nurse navigator at Clearview Cancer Center in Huntsville, Alabama.
Key Learning Outcomes
- Describe new treatment modalities for lung cancer, including targeted therapy and immunotherapy.
- Discuss adverse effects of new lung cancer treatment modalities.
- Describe how to help patients manage common side effects of new treatment modalities.
